Ultimate predictability Since 1999, genOway aims at bridging the gap between preclinical findings and clinical success with advanced, genetically engineered preclinical models and solutions. From customized mice and rats to ready-to-use cell lines, our solutions provide increased predictability and accelerate therapeutic breakthroughs. We work with 17 of the world’s Top pharma companies—as well as leading biotech firms, CROs, and academic institutions. At the heart of genOway is a team of 150+ skilled professionals, from 17 nationalities, all committed to advancing preclinical research. What We Offer • A catalogue of validated, ready-to-use mice and cell lines—developed in partnership with biopharma leaders …

58 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Bedrock of Biotech Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing …

27 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Genome Optimised Data Store: Enabling healthcare transformation using big data technology Zetta Genomics unleashes the power of precision medicine – shaping the future of genomic data to transform the health of millions of people around the world. bioinformatics, genomics, genomic medicine, precision medicine, and biomedical research

115 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics

More Omics into Clinics Pioneering the integration of DNA & RNA sequencing data with AI for rare disease diagnostics Follow us on Twitter @PhiTech_Bioinfo Bioinformatics, Genomics, Transcriptomics, Epigenomics, AI, and Rare Diseases

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is …

40 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection

85 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

BiogeniQ helps people optimize their nutrition and medication based on their genetic composition. We allow everyone to access important portions of their DNA, while providing a useful tool for healthcare professionals. We put emphasis on solid, peer-reviewed research and integration of our genetic reports into future healthcare. Médecine Personnalisée, Dépistage Génétique, Nutrigénomique, Pharmacogénétique, Génotypage, and Génomique

21 similar entities Type: Startup Activities: biotech deeptech

Unlock genomic insights Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. Genomics, Human Genetics, Big Data, and Algorithms

153 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. A.I. - Machine Learning

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

165 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker

7 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics

Genetics is advancing at a rapid pace, transforming research and revolutionising the way we diagnose and treat complex diseases such as heart disease and cancer. We are a team of scientists and developers specialised in genetics and bioinformatics, determined to increase access to genomic medicine in the clinic. We develop innovative solutions to make genomic medicine more accessible, partnering with a portfolio of private and public laboratories in the UK and overseas. Our approach is strongly shaped by our scientific background and experience. Our flexible, powerful online ordering platform for genetic tests enables clinicians to find and order tests for …

Type: Startup Activities: biotech deeptech Technologies: SaaS

Award-winning precision health platform delivering personalized wellness solutions through genomics and deep science. LifeNome is a globally recognized leader transforming personalized health and longevity through cutting-edge AI, genomics, systems biology, and multi-omics science. Our precision health platform delivers tailored wellness and preventive care solutions for healthcare, insurance, pharmaceutical, nutrition, and fitness sectors worldwide. We empower partners to enhance health outcomes and lower costs with actionable, data-driven insights in key areas: Precision preventive health, including early disease risk detection and AI-driven intervention design Maternal and family health solutions focused on fertility, prenatal, and postpartum care Personalized nutrition and wellbeing based on …

57 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of …

60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Machine Learning Synthetic Biology